Hypertensive diabetic patients. Guidelines for conduct and their difficulties;Hipertenso diabético. Diretrizes de atuação e suas dificuldades

Arquivos Brasileiros de Cardiologia

Volumn 81, Issue 2, 2003, Pages 137-147

  Barroso, Weimar K S ^a   Jardim, Paulo César B V ^a   Jardim, Thiago S V ^a   Souza, Cláudio T S ^a   Magalhães, Alessandro L A ^a   Ibrahim, Fuad M ^a   Couto, Priscila V O ^a   Silveira, Andrea ^a   Monego, Estelamaris T ^a  

^a NONE

Author keywords

Diabetes; Hypertension; Treatment

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; INSULIN; POTASSIUM;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DRUG COST; ECONOMIC ASPECT; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SERVICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT REFERRAL; PRACTICE GUIDELINE; RISK FACTOR; SEX DIFFERENCE; SOCIAL ASPECT; TREATMENT PLANNING;

EID: 0041818322     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2003001000003     Document Type: Article

References (27)

1. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 349: 454-57.
2. 1999 World Health Organization - International Society of Hypertension Guidelines for the management of Hypertension. J Hypertens 1999; 17: 151-183.
3. III Consenso Brasileiro de Hipertensão Arterial. HiperAtivo 1999; 6: 67-106.
4. Berlowitz DZ, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in hypertensive population. N Engl J Med 1998; 339: 1957-63.
5. Arauz-Pacheco C, Parrot M, Raskin P. The treatment of hypertension in adult patient with diabetes. Diabetes Care 2002; 25 (supl.1): 134-47.
6. Basta M, Bakris G. Escolhas e metas no tratamento do paciente diabético hipertenso. Curr Hypertens Rep Brasil 2001;1:286-90.
7. Deedwania P.C. Hypertension and diabetes. New therapeutic options. Arch Intern Med 2000; 160:1585-94.
8. Sowers J R. Diabetes and hypertension. Cur. Concepts in Hypertension 1999; 3:2-4.
9. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of Intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-62.
10. UK prospective diabetes study group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.
11. Maschio G, Albert D, Janin G. et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-45.
12. Estacio R, Jeffers B W, Hiatt W R, Biggerstaff S L, Gifford N, Schirier R W. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645-52.
13. Bakris G L, Williams M, Dworkin L. et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Fundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36:646-61.
14. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. The heart outcomes prevention evaluation study investigators: effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-53.
15. Gress T W, Nieto J, Shahar E, Wofford M, Brancati F. Hypertension and antihypertensive therapy as risk factors for type 2 Diabetes Mellitus. N Engl J Med 2000; 342: 905-12.
16. Niskanen L, Hedner T, Hansson L, Lanke J, Niklason A for the CAPPP study group. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-bases treatment regimen: a subanalysis of the captopril prevention project. Diabetes 2001; 24 (supl. XII): 2091-96.
17. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
18. Prisant L M, Louard R J. Controversies surrounding the treatment of the hypertensive patient with diabetes. Curr Hypertens Rep 1999; 1: 512-20.
19. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276: 1886-92.
20. Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) Randomised Trial. Lancet 1999; 353: 611-6.
21. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-60.
22. Parving H H, Lehnert H, Brochner-Mortensen J, et al. The effects of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-8.
23. Brenner BM, Cooper ME, Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropaty. N Engl J Med 2001; 345: 861-9.
24. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. JAMA 1992; 267: 1213-20.
25. 2° Consenso Brasileiro sobre Dislipidemias-Detecçã o-Avaliação-Tratamento. Arq Bras Cardiol 1996; 67 (supl): 1-16.
26. Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation 2000; 101: 207-13.
27. Grundy S M, Benjamin I J, Burke G L, et al. Diabetes and cardiovascular disease. A statment for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134-46.